May 7, 2025, 22:31

Promising Scientist Grant

The Promising Scientist Grant from Kids Beating Cancer offers continued support to recipients of the Emerging Scientist Grant who are ready to take the next step in their research journey. This 25,000 USD award funds short-term, self-contained research projects that fall within a larger scientific investigation in pediatric cancer.

Who is eligible?

Applicants must:

Have successfully completed the Emerging Scientist Grant within the past two years
Be a graduate student (master’s, PhD, or MD) or a postdoctoral researcher (within two years of degree)
Work under the direct supervision of a U.S.-based mentor specializing in pediatric cancer research
Submit a letter of support from their mentor
Be affiliated with a U.S.-based nonprofit or academic institution
Submit original, unpublished work or significantly updated abstracts from major conferences (e.g., ASCO, ASH, ASPHO, AACR)

Funding at a glance:

25,000 USD total
Project length: 3–6 months
At least 80% of funds must support the trainee’s direct involvement (e.g., supplies, labor, equipment)
Indirect costs, PR, memberships, travel, or admin fees are not allowed

Research focus:

The proposed research must be relevant to pediatric cancer. The project should be discrete, capable of being completed in a few months, and clearly fit into a broader research plan. Projects might include mechanistic studies, drug screening, animal models, or sequencing analysis of resistant cancer subtypes.

Key deadlines:

Application Deadline: October 1, 2025
Award Notification: November 1, 2025
Final Report Due: October 31, 2026

Where to apply:

Submit the application via ProposalCentral using NIH-style formatting. A final report is required from both trainee and mentor.

Questions?

Sam Azar, COO & VP of Research – [email protected]
Ian Henrich, PhD, Chair, Scientific Advisory Board – [email protected]

biomedical research cancer funding cancer innovation Childhood Cancer early-career scientists emerging researchers graduate research Kids Beating Cancer OncoDaily Pediatric cancer postdoctoral grant Promising Scientist Grant proposalCENTRAL translational research

Agenus Bets Big on Botensilimab

Carlos Rodriguez-Galindo: Childhood cancer has long been overlooked in global strategies - It is time to change that

EMBER-3 Trial Updates from ESMO Breast 2025: Imlunestrant Plus Abemaciclib Improves PFS in CDK4/6i-Pretreated ER+/HER2- Breast Cancer

FDA Grants Accelerated Approval for Telisotuzumab Vedotin (EMRELIS™) in c-MET–Overexpressing Advanced Non-Small Cell Lung Cancer

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research